Author: healthylife7

A taste of Carnival with a high-energy performance featuring Deise Costa and the Brazilian Swag dancers on the stage at Hog Wild on Friday at Civic Field in Port Angeles. (Dave Logan/for Peninsula Daily News)

The advent of the GLP-1 and GIP agonist drugs has brought along with it an increased focus on “food noise.” Many people on one or both of those medications report a serious reduction in food noise, which has been defined as “intrusive and often unwanted thoughts about food.” As more and more research has emerged,…

The Supreme Court on Tuesday said elephants serving in temples must be respected and treated as manifestations of divinity while issuing a series of directions concerning the upkeep, health and wellbeing of captive elephants across the country

“People have estimated that out of all the people who need palliative care, how many actually get it? It’s about 5%.”

The defense continues calling witnesses in the high-profile Massachusetts murder trial of Lindsay Clancy, who is accused of killing her three young children

Carlsquare Equity Research has published a comment on today’s news regarding EMA approval for the start of a new clinical trial for XEN-D0501

The island’s military is working to learn the lessons of the Ukraine war and boost its asymmetric defences against the PLA

Texas Educators Link Weekend Nutrition to Monday Classrooms in Snack Pak 4 Kids® Survey

Glucagon-like peptide 1 (GLP-1) receptor agonist drugs have been on the forefront as a promising treatment for multiple health issues — specifically in the management of type 2 diabetes and weight management

Kailera Therapeutics (NASDAQ:KLRA) closed most recently at $18.51, between a post-IPO high of $28.23 and low of $16.39, with a $2.40 billion market cap. Shares are down 2.5% on the week and 28.8% since shares began trading in April. Kailera holds $1.17 billion in cash and marketable securities, posted a Q2 net loss of $111.31…